Post-market clinical follow-up for stenfilcon A sphere and toric lenses

This study aims to assess post-market safety and performance of stenfilcon A sphere, toric and multifocal contact lenses

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN61640561

Enrollment

135

Registered

2024-03-26

Start date

2024-04-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, astigmatism, hyperopia Eye Diseases

Interventions

The potential participant will attend the clinic for one study visit wearing the study contact lenses and having worn the study contact lenses for at least 3 hours that day. The visit will be about 2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 07/03/2025: 1. Aged 8 to 75 years old (inclusive) 2. Current wearer of the Stenfilcon A Sphere, Toric or Multifocal contact lens Previous participant inclusion criteria: 1. Aged 8 to 75 years old (inclusive) 2. Current wearer of the Stenfilcon A Sphere or Toric contact lens

Exclusion criteria

Exclusion criteria: 1. Participation in a contact lens or contact lens care product clinical trial within the previous 30 days

Design outcomes

Primary

Measure	Time frame
1. Visual performance measured using a visual acuity chart at the single study visit 2. Incidence of contact lens-related adverse events measured using a report of contact lens related adverse events in the past 12 months at the single study visit	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

England, Scotland, United Kingdom

Contacts

Public ContactDanny Leung

dleung@coopervision.com+1 (0)9256604360

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026